> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Workshop on Modeling/Simulation for Oncology Products
- URL: https://www.fdaweb.com/workshop-on-modeling-simulation-for-oncology-products/
- Published: 2018-02-01T12:00:00.000Z
- Updated: 2026-09-14T23:19:06.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140657

*Federal Register* notice: FDA has announced a 2/1 public workshop entitled “Best Practices in Modeling and Simulation for Oncology Products.” The meeting will discuss integrating pharmacokinetic, pharmacodynamic, efficacy, and safety data into models to best inform oncology drug development, evaluate disease- and mechanism-specific early endpoints to predict long-term efficacy, and discuss potential regulatory implications of model-informed decisions in drug development. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-02-01/pdf/2018-01992.pdf?ref=fdaweb.com).